1-4 of 4
Tomofumi Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elucidation of the IMiDs-Resistant Mechanism and Development of the Overcoming Drugs Inducing CRBN Independent G2/M Cell Cycle Arrest in Myeloma Cells

Ryo Uozaki, Shuji Aida, Takasi Yamagughi, Tomofumi Yamamoto, BPharm, Sho Kashiwazaki, Hiroshi Yanagawa, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori
Journal: Blood
Blood (2018) 132 (Supplement 1): 4451.
https://doi.org/10.1182/blood-2018-99-115909
Published: 2018
Journal Articles

Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma

Sho Kashiwazaki, Satoshi Kamiko, Ryo Uozaki, Tomofumi Yamamoto, BPharm, Daiju Ichikawa, Yutaka Hattori, Maiko Matsushita, Maki Hirao, Hisako Kunieda, Kohei Yamazaki
Journal: Blood
Blood (2018) 132 (Supplement 1): 1946.
https://doi.org/10.1182/blood-2018-99-115894
Published: 2018
Journal Articles

Understanding the Role of Extracellular Vesicles in Lenalidomide-Resistance Multiple Myeloma

Tomofumi Yamamoto, BPharm, Nobuyoshi Kosaka, PhD, Ochiya Takahiro, PhD, Yutaka Hattori
Journal: Blood
Blood (2018) 132 (Supplement 1): 1887.
https://doi.org/10.1182/blood-2018-99-115730
Published: 2018
Journal Articles

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Kenshi Suzuki, MD PhD, Tomofumi Yamamoto, Masahiro Ikeda, MD, Tomomi Takei, MD, Nobuhiro Tsukada, MD PhD, Tadao Ishida, MD PhD, Arimi Ueda, Daiju Ichikawa, PhD, Maiko Matsushita, MD PhD, Yutaka Hattori, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5620.
https://doi.org/10.1182/blood.V128.22.5620.5620
Published: 2016